[1] Sung H, Ferlay J, Siegel R L, Laversanne M, Soerjomataram I,
Jemal A and Bray F 2021 Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality
worldwide for 36 cancers in 185 countries CA Cancer J. Clin.
71 209–49
[2] Coleman C 2017 Early detection and screening for breast
cancer Semin. Oncol. Nurs. 33 141–55
[3] Tohno E, Ueno E and Watanabe H 2009 Ultrasound
screening of breast cancer Breast Cancer 16 18–22
[4] Minamimoto R, Senda M, Jinnouchi S, Terauchi T,
Yoshida T and Inoue T 2015 Detection of breast cancer in an
FDG-PET cancer screening program: results of a nationwide
Japanese survey Clin. Breast Cancer 15 e139–46
[5] Løberg M, Lousdal M L, Bretthauer M and Kalager M 2015
Benefits and harms of mammography screening Breast
Cancer Res. 17 63
[6] Hing J X, Mok C W, Tan P T, Sudhakar S S, Seah C M,
Lee W P and Tan S M 2020 Clinical utility of tumour marker
velocity of cancer antigen 15-3 (CA 15-3) and
carcinoembryonic antigen (CEA) in breast cancer
surveillance Breast 52 95–101
[7] Tay T K Y and Tan P H 2021 Liquid biopsy in breast cancer: a
focused review Arch. Pathol. Lab. Med. 145 678–86
[8] Li J, Guan X, Fan Z, Ching L M, Li Y, Wang X, Cao W M and
Liu D X 2020 Non-invasive biomarkers for early detection of
breast cancer Cancers 12 2767
[9] Sant M, Bernat-Peguera A, Felip E and Margelí M 2022 Role
of ctDNA in breast cancer Cancers 14 310
[10] Hackshaw A, Clarke C A and Hartman A R 2022 New
genomic technologies for multi-cancer early detection:
rethinking the scope of cancer screening Cancer Cell
40 109–13
[11] Kumar D N, Chaudhuri A, Aqil F, Dehari D, Munagala R,
Singh S, Gupta R C and Agrawal A K 2022 Exosomes as
emerging drug delivery and diagnostic modality for breast
cancer: recent advances in isolation and application Cancers
14 1435
[12] Vietri M T, D’Elia G, Benincasa G, Ferraro G, Caliendo G,
Nicoletti G F and Napoli C 2021 DNA methylation and
breast cancer: a way forward (review) Int. J. Oncol. 59 98
[13] Coronel-Hernández J, Pérez-Yépez E A, Delgado-Waldo I,
Contreras-Romero C, Jacobo-Herrera N, Cant´
u-De León D
J. Breath Res. 17 (2023) 016006
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
Y Nakayama et al
and Pérez-Plasencia C 2021 Aberrant metabolism as
inductor of epigenetic changes in breast cancer: therapeutic
opportunities Front. Oncol. 11 676562
Vignoli A, Risi E, McCartney A, Migliaccio I, Moretti E,
Malorni L, Luchinat C, Biganzoli L and Tenori L 2021
Precision oncology via NMR-based metabolomics: a review
on breast cancer Int. J. Mol. Sci. 22 4687
Zhang A H, Sun H, Qiu S and Wang X J 2013 Metabolomics
in noninvasive breast cancer Clin. Chim. Acta 424 3–7
da Costa B R B and De Martinis B S 2020 Analysis of urinary
VOCs using mass spectrometric methods to diagnose cancer:
a review Clin. Mass Spectrom. 18 27–37
Patterson S G, Bayer C W, Hendry R J, Sellers N, Lee K S,
Vidakovic B, Mizaikoff B and Gabram-Mendola S G 2011
Breath analysis by mass spectrometry: a new tool for breast
cancer detection? Am. Surg. 77 747–51
Li J, Peng Y, Liu Y, Li W, Jin Y, Tang Z and Duan Y 2014
Investigation of potential breath biomarkers for the early
diagnosis of breast cancer using gas chromatography-mass
spectrometry Clin. Chim. Acta 436 59–67
Zhang Y, Guo L, Qiu Z, Lv Y, Chen G and Li E 2020 Early
diagnosis of breast cancer from exhaled breath by gas
chromatography-mass spectrometry (GC/MS) analysis: a
prospective cohort study J. Clin. Lab. Anal. 34 e23526
Yang H Y, Wang Y C, Peng H Y and Huang C H 2021 Breath
biopsy of breast cancer using sensor array signals and
machine learning analysis Sci. Rep. 11 103
Herman-Saffar O, Boger Z, Libson S, Lieberman D, Gonen R
and Zeiri Y 2018 Early non-invasive detection of breast
cancer using exhaled breath and urine analysis Comput. Biol.
Med. 96 227–32
Oakley-Girvan I and Davis S W 2017 Breath based volatile
organic compounds in the detection of breast, lung, and
colorectal cancers: a systematic review Cancer Biomark
21 29–39
Hastie C, Thompson A, Perkins M, Langford V S,
Eddleston M and Homer N Z 2021 Selected ion flow
tube-mass spectrometry (SIFT-MS) as an alternative to gas
chromatography/mass spectrometry (GC/MS) for the
analysis of cyclohexanone and cyclohexanol in plasma ACS
Omega 6 32818–22
La Nasa J, Modugno F, Colombini M P and Degano I 2019
Validation study of selected ion flow tube-mass spectrometry
(SIFT-MS) in heritage science: characterization of natural
and synthetic paint varnishes by portable mass spectrometry
J. Am. Soc. Mass Spectrom. 30 2250–8
Wang M H, Chong K C, Storer M, Pickering J W, Endre Z H,
Lau S Y, Kwok C, Lai M, Chung H Y and Ying Zee B C 2016
Use of a least absolute shrinkage and selection operator
(LASSO) model to selected ion flow tube mass spectrometry
(SIFT-MS) analysis of exhaled breath to predict the efficacy
of dialysis: a pilot study J. Breath Res. 10 046004
Smith D and Spanel P 2005 Selected ion flow tube mass
spectrometry (SIFT-MS) for on-line trace gas analysis Mass
Spectrom. Rev. 24 661–700
Spane
ˇl P and Smith D 2011 Progress in SIFT-MS: breath
analysis and other applications Mass Spectrom. Rev.
30 236–67
Carrapiso A I, Noseda B, García C, Reina R, Del Pulgar J S
and Devlieghere F 2015 SIFT-MS analysis of Iberian hams
from pigs reared under different conditions Meat Sci.
104 8–13
Dharmawardana N, Goddard T, Woods C, Watson D I,
Ooi E H and Yazbeck R 2020 Development of a non-invasive
exhaled breath test for the diagnosis of head and neck cancer
Br. J. Cancer 123 1775–81
Pang Z, Chong J, Zhou G, de Lima Morais D A, Chang L,
Barrette M, Gauthier C, Jacques P, Li S and Xia J 2021
MetaboAnalyst 5.0: narrowing the gap between raw spectra
and functional insights Nucleic Acids Res. 49 W388–w96
de Lacy Costello B, Amann A, Al-Kateb H, Flynn C,
Filipiak W, Khalid T, Osborne D and Ratcliffe N M 2014 A
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
review of the volatiles from the healthy human body J.
Breath Res. 8 014001
Zhu L and Bakovic M 2012 Breast cancer cells adapt to
metabolic stress by increasing ethanolamine phospholipid
synthesis and CTP:ethanolaminephosphate
cytidylyltransferase-Pcyt2 activity Biochem. Cell Biol.
90 188–99
Kiss Z and Crilly K S 1995 Tamoxifen inhibits uptake and
metabolism of ethanolamine and choline in
multidrug-resistant, but not in drug-sensitive, MCF-7
human breast carcinoma cells FEBS Lett. 360 165–8
Kano-Sueoka T, Watanabe T, Miya T and Kasai H 1991
Analysis of cytosolic phosphoethanolamine and
ethanolamine and their correlation with prognostic factors
in breast cancer Jpn. J. Cancer Res. 82 829–34
Shin E and Koo J S 2021 Glucose metabolism and glucose
transporters in breast cancer Front. Cell Dev. Biol. 2404
Wang Y, Li Y, Yang J, Ruan J and Sun C 2016 Microbial
volatile organic compounds and their application in
microorganism identification in foodstuff TrAC Trends Anal.
Chem. 78 1–16
Li L T, Jiang G, Chen Q and Zheng J N 2015 Ki67 is a
promising molecular target in the diagnosis of cancer
(review) Mol. Med. Rep. 11 1566–72
Martinez-Lozano Sinues P, Landoni E, Miceli R, Dibari V F,
Dugo M, Agresti R, Tagliabue E, Cristoni S and Orlandi R
2015 Secondary electrospray ionization-mass spectrometry
and a novel statistical bioinformatic approach identifies a
cancer-related profile in exhaled breath of breast cancer
patients: a pilot study J. Breath Res. 9 031001
Peng G, Hakim M, Broza Y Y, Billan S, Abdah-Bortnyak R,
Kuten A, Tisch U and Haick H 2010 Detection of lung,
breast, colorectal, and prostate cancers from exhaled breath
using a single array of nanosensors Br. J. Cancer 103 542–51
Wang C et al 2014 Volatile organic metabolites identify
patients with breast cancer, cyclomastopathy, and mammary
gland fibroma Sci. Rep. 4 5383
Phillips M, Cataneo R, Lebauer C, Mundada M and
Saunders C 2017 Breath mass ion biomarkers of breast
cancer J. Breath Res. 11 016004
Thriumani R, Zakaria A, Hashim Y Z H, Jeffree A I,
Helmy K M, Kamarudin L M, Omar M I, Shakaff A Y M,
Adom A H and Persaud K C 2018 A study on volatile organic
compounds emitted by in-vitro lung cancer cultured cells
using gas sensor array and SPME-GCMS BMC Cancer
18 362
Liu Y, Li W and Duan Y 2019 Effect of H(2)O(2) induced
oxidative stress (OS) on volatile organic compounds (VOCs)
and intracellular metabolism in MCF-7 breast cancer cells J.
Breath Res. 13 036005
Ebeler S E, Clifford A J and Shibamoto T 1997 Quantitative
analysis by gas chromatography of volatile carbonyl
compounds in expired air from mice and human J.
Chromatogr. B 702 211–5
Abderrahman B 2019 Exhaled breath biopsy: a new cancer
detection paradigm Future Oncol. 15 1679–82
Rodríguez-Aguilar M et al 2021 Application of
chemoresistive gas sensors and chemometric analysis to
differentiate the fingerprints of global volatile organic
compounds from diseases. Preliminary results of COPD,
lung cancer and breast cancer Clin. Chim. Acta
518 83–92
Rondanelli M, Perdoni F, Infantino V, Faliva M A, Peroni G,
Iannello G, Nichetti M, Alalwan T A, Perna S and Cocuzza C
2019 Volatile organic compounds as biomarkers of
gastrointestinal diseases and nutritional status J. Anal.
Methods Chem. 2019 7247802
van Keulen K E, Jansen M E, Schrauwen R W M, Kolkman J J
and Siersema P D 2020 Volatile organic compounds in
breath can serve as a non-invasive diagnostic biomarker for
the detection of advanced adenomas and colorectal cancer
Aliment. Pharmacol. Ther. 51 334–46
...
論文の公開元へ
